• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠口服14C-β-环糊精后的吸收、分布、排泄及代谢

Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.

作者信息

Gerlóczy A, Fónagy A, Keresztes P, Perlaky L, Szejtli J

出版信息

Arzneimittelforschung. 1985;35(7):1042-7.

PMID:4052138
Abstract

The absorption, distribution, excretion and metabolism of orally administered universally labelled 14C-beta-cyclodextrin and 14C-glucose were compared in rat. The maximum radioactivity of the blood derived from 14C-beta-cyclodextrin was observed between 4th and 11th h and the value of the maximum in different experiments ranged between 5 and 17 0/00 of the total administered radioactivity. Following 14C-glucose treatment radioactivity reached the maximum within half-an-hour, with values of 15 to 82 0/00. In the 8th h after a high dose (313.5 mg/kg) of beta-cyclodextrin no more than 3-50 ppm beta-cyclodextrin was detectable in the blood by HPLC. After 14C-beta-cyclodextrin treatment 4.2-4.8% of the administered total radioactivity was excreted by the urine and about the same quantity (2-3.6%) in case of 14C-glucose. No specific accumulation was observed after 14C-beta-cyclodextrin treatment in the different organs. The large intestine contained 10-15% of the cyclodextrin radioactivity while this value was only 2% in case of 14C-glucose. Following p.o. administration of different doses of 14C-beta-cyclodextrin the radioactivity peak was detected in the exhaled air between the 4-6th and 6-8th h, respectively, depending on the administered doses, while in case of 14C-glucose treatment it was observed within 2 h. The total radioactivity exhaled by 14C-beta-cyclodextrin treated animals in 24 h was 55 to 64% of the administered radioactivity and 58% in case of 14C-glucose. It is assumed that beta-cyclodextrin is metabolized in rats slower but similarly to glucose, therefore p.o. administered beta-cyclodextrin cannot induce toxic symptoms.

摘要

在大鼠体内比较了口服通用标记的14C-β-环糊精和14C-葡萄糖的吸收、分布、排泄及代谢情况。源自14C-β-环糊精的血液中放射性在第4至11小时达到最大值,不同实验中最大值在总给药放射性的5至17‰之间。给予14C-葡萄糖后,放射性在半小时内达到最大值,数值为15至82‰。在高剂量(313.5mg/kg)β-环糊精给药后第8小时,通过高效液相色谱法在血液中检测到的β-环糊精不超过3 - 50ppm。给予14C-β-环糊精后,4.2 - 4.8%的总给药放射性通过尿液排出,14C-葡萄糖的情况约为相同数量(2 - 3.6%)。给予14C-β-环糊精后,在不同器官中未观察到特异性蓄积。大肠中含有10 - 15%的环糊精放射性,而14C-葡萄糖的该值仅为2%。口服不同剂量的14C-β-环糊精后,呼出空气中的放射性峰值分别在第4 - 6小时和第6 - 8小时检测到,具体取决于给药剂量,而给予14C-葡萄糖后在2小时内观察到。14C-β-环糊精处理的动物在24小时内呼出的总放射性为给药放射性的55%至64%,14C-葡萄糖为58%。据推测,β-环糊精在大鼠体内的代谢比葡萄糖慢但类似,因此口服β-环糊精不会引发毒性症状。

相似文献

1
Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.大鼠口服14C-β-环糊精后的吸收、分布、排泄及代谢
Arzneimittelforschung. 1985;35(7):1042-7.
2
Intestinal absorption of 14C-labelled beta-cyclodextrin in rats.大鼠对14C标记的β-环糊精的肠道吸收
Arzneimittelforschung. 1980;30(5):808-10.
3
Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.N,N-二乙基间甲苯酰胺在大鼠体内的吸收、分布、代谢及排泄
Drug Metab Dispos. 1996 Feb;24(2):156-63.
4
Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.[14C]γ-环糊精在无菌大鼠和普通大鼠体内的处置情况。
Regul Toxicol Pharmacol. 1998 Apr;27(2):150-8. doi: 10.1006/rtph.1998.1219.
5
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.硫酸氨基葡萄糖的吸收、分布、代谢及排泄。综述
Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105.
6
Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats.14C-α-环糊精在无菌大鼠和普通大鼠体内的处置情况。
Regul Toxicol Pharmacol. 2004 Jun;39 Suppl 1:57-66. doi: 10.1016/j.yrtph.2004.05.011.
7
Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.大鼠单次给药后[14C]依巴斯汀的吸收、分布、代谢和排泄
Arzneimittelforschung. 1994 Apr;44(4):527-38.
8
Influencing of resorption and side-effects of salicylic acid by complexing with beta-cyclodextrin.
Pharmazie. 1981 Apr;36(4):283-6.
9
Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.普卢利沙星的药代动力学。首次通信:单次给药后在大鼠、狗和猴子体内的吸收、分布及排泄情况
Arzneimittelforschung. 1997 Mar;47(3):276-84.
10
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.

引用本文的文献

1
Host-Guest Complexes of Flavanone and 4'-Chloroflavanone with Naturals and Modified Cyclodextrin: A Calorimetric and Spectroscopy Investigations.黄烷酮和4'-氯黄烷酮与天然及改性环糊精的主客体配合物:量热法和光谱学研究
Molecules. 2024 Jun 30;29(13):3123. doi: 10.3390/molecules29133123.
2
A rotaxane-based platform for tailoring the pharmacokinetics of cancer-targeted radiotracers.一种用于定制癌症靶向放射性示踪剂药代动力学的基于轮烷的平台。
Chem Sci. 2022 Oct 11;13(43):12713-12725. doi: 10.1039/d2sc03928a. eCollection 2022 Nov 9.
3
Studies of the Formation and Stability of Ezetimibe-Cyclodextrin Inclusion Complexes.
研究依泽替米贝-环糊精包合物的形成和稳定性。
Int J Mol Sci. 2021 Dec 31;23(1):455. doi: 10.3390/ijms23010455.
4
Piroxicam-β-cyclodextrin: a GI safer piroxicam.吡罗昔康-β-环糊精:一种胃肠道安全性更高的吡罗昔康。
Curr Med Chem. 2013;20(19):2415-37. doi: 10.2174/09298673113209990115.
5
Colonic drug delivery: prodrug approach.结肠给药:前药方法。
Pharm Res. 2001 May;18(5):557-64. doi: 10.1023/a:1011033121528.
6
Cyclodextrins: their future in drug formulation and delivery.环糊精:它们在药物制剂与递送方面的未来。
Pharm Res. 1997 May;14(5):556-67. doi: 10.1023/a:1012136608249.
7
Hypolipidemic effects of beta-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat.β-环糊精对仓鼠和遗传性高胆固醇血症里科大鼠的降血脂作用。
Lipids. 1993 Mar;28(3):181-8. doi: 10.1007/BF02536637.
8
Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.吡罗昔康-β-环糊精。对其药效学和药代动力学特性以及在风湿性疾病和疼痛状态中的治疗潜力的综述。
Drugs. 1994 Dec;48(6):907-29. doi: 10.2165/00003495-199448060-00007.
9
The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.大鼠体内β-环糊精和羟丙基-β-环糊精的药代动力学
Pharm Res. 1990 Dec;7(12):1248-52. doi: 10.1023/a:1015929720063.